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COMMENTARY Open Access
Are we there yet? An update on
transitional care in rheumatology
Janet E. McDonagh1,2,3* and Albert Farre4,5
Abstract
Significant progress has been made in the understanding of transitional care in rheumatology over the last few
decades, yet universal implementation has not been realised and unmet needs continue to be reported. Possible
explanations for this include lack of evidence as to which model is most effective; lack of attention to the multiple
dimensions, stakeholders and systems involved in health transitions; and lack of consideration of the developmental
appropriateness of transition interventions and the services/organisations/systems where such interventions are
delivered.
Successful transition has major implications to both the young people with juvenile-onset rheumatic disease and
their families. Future research in this area will need to reflect both the multidimensional (biopsychosocial) and the
multisystemic (multiple systems and stakeholders across personal/social/family support networks and health/social
care/education systems). Only then will we be able to determine which aspects of transition readiness and service
components influence which dimension. It is therefore imperative we continue to research and develop this area,
involving both paediatric and adult rheumatology clinicians and researchers, remembering to look beyond both the
condition and our discipline. Neither should we forget to tap into the exciting potential associated with digital
technology to ensure further advances in transitional care are brought about in and beyond rheumatology.
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Background
It is now 25 years since the first transitional care
programme in rheumatology was reported and a decade
since the first objective evaluation of such a programme
[1]. Since then other programmes have been described
[2] and international guidelines developed [3], all learn-
ing from similar progress elsewhere [4, 5]. In spite of
this, universal implementation has not been realised and
unmet needs continue to be reported [6]. The aims of
this paper are to explore why this should be, consider
the current shortcomings of the existing evidence, and
propose an itinerary for the next leg of the transitional
care research journey.
Main text
The rationale and aims of transitional care with juvenile-
onset rheumatic disease (jRMD) are well established [1–3]
and the evidence of need for transitional care in rheuma-
tology is no longer disputed [3]. Why then are unmet
needs in this area still reported [6]?
Various transition models and approaches to its evalu-
ation have been reported in the literature [1, 2, 4]. How-
ever, it is not yet known which model is the most
effective and it remains unclear how to measure the effi-
cacy and outcomes of such a multifaceted and protracted
intervention, which extends from early adolescence
through to the third decade. A Delphi study involving a
range of professionals identified 10 outcomes, the majority
of which were health service related except for two
patient-reported outcomes, ‘optimal quality of life’ and ‘a
social network’, and none included vocational or psycho-
logical outcomes [5]. Similarly, randomised controlled tri-
als to date have primarily employed health service-related
measures [4]. Thus, existing outcome measures still fail to
reflect all aspects of transitional care: biological (disease),
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psychological, social and educational/vocational. Further-
more, the lack of accepted transition outcome measures
further hampers transition research [5].
Likewise, various transition readiness measures and
checklists have been reported in the literature [7], and
although their use is advocated in current guidance [3]
they are not used universally in practice [6]. Two key
challenges are: due to the interrelated nature of adoles-
cent development, measures are likely to reflect transi-
tion readiness trajectories over the broader life stage,
rather than selectively reflecting healthcare transition
readiness; and it is largely unknown as to when such
readiness skills should be developing. Furthermore, some
measures fail to encompass all aspects of adolescent de-
velopment relevant to healthcare transitions. For ex-
ample, not all measures used in European rheumatology
centres consider educational and vocational develop-
ment [6], which is concerning in view of the vocational
morbidity of jRMD in this age group [8]. Also, currently
available tools are based on self-reporting, which may
not evaluate all aspects of mastery of ‘transition’ skills.
Finally, consideration of the setting (whether health,
home and/or school) in which young people practise
these skills is also important. A young person may be
‘transition-ready’ but if a particular setting does not sup-
port/promote positive youth development, the develop-
ment of such skills may be delayed due to lack of
opportunity.
A frequently reported barrier to implementation in-
cludes lack of resources. A key resource is the availabil-
ity of trained staff. There is a significant association
between youth perceptions of autonomy support from
their rheumatologist and healthcare transition discus-
sions [9]. The use of the HEEADSSS tool has been advo-
cated by several authors, and is now referenced
(alongside appropriate training in adolescent health) in
the EULAR recommendations [3, 6, 9]. However, poten-
tial efficacy of current training should be considered in
view of reported discrepancies between professionals
and young people as to which topics are actually dis-
cussed in clinics [10]. Such issues should be taken into
consideration going forward.
In view of the generic nature of the developmental
needs of young people with long-term health conditions,
one could argue that transitional care programmes can
be generic rather than disease specific, with the resulting
potential efficiencies of scale in terms of resources and
funding. Likewise, research should consider a generic ap-
proach whether within disciplines or across disciplines.
The latter is particularly important so as to learn from
other disciplines and thereby not slow down progress in
this field. Alongside this, further improvement can be fa-
cilitated by digital technology, which is still perceived as
underused in transitional care [6, 11].
A key area less studied to date is the health system/
regulatory framework where such care is being provided.
Young people experience health transitions across a
range of settings, not just rheumatology clinics. Flexibil-
ity, funding and cross-sectoral collaboration (including
communication and coordination) at the system level
have been identified as areas in need of further improve-
ment [12]. The need to secure funding for provision of
transitional care is a welcome inclusion in the EULAR
recommendations [3].
Another less researched area is consideration of how
developmentally appropriate a particular programme/
service is, including the institution it is delivered within.
Too often, health transition is considered merely as the
negotiation of the structural boundaries between child
and adult services rather than a holistic approach to the
developmental needs of young people as they grow up
and negotiate multiple transitions of which healthcare is
only one. Provision of developmentally appropriate
health care [13] is a potential facilitator of health transi-
tion and is the backdrop on which health transition
should always be considered [14].
Conclusions
Young people with jRMD in the UK recently reported
transition as a research priority [15] and whilst acknow-
ledging the progress so far, there is much left to do. Future
research will need to reflect both the multidimensional
(biopsychosocial) and the multisystemic (multiple systems
and stakeholders across personal/social/family support
networks and health/social care/education systems). Only
then will we be able to determine which aspects of transi-
tion readiness and service components influence which di-
mension. Successful transition has major implications to
both the young people with jRMD and their families as
well as to cohort studies and registries. It is therefore im-
perative we continue to research and develop this area, in-
volving both paediatric and adult rheumatology clinicians
and researchers, and not forgetting to look beyond the
condition and our discipline so as not to reinvent un-
necessary wheels.
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